OTC: Potential Drug Targets Or Biomarkers for Various Diseases

Target Name: OTC

NCBI ID: G5009

Content of Review Report on OTC Target / Biomarker

OTC

OTC: Potential Drug Targets Or Biomarkers for Various Diseases

OTC (Ornithine transcarbamylase, mitochondrial), a protein encoded in the mitochondrial DNA, is a crucial enzyme for the metabolism of ornithine, a crucial amino acid that plays a vital role in the production of proteins and nucleic acids. Mitochondria are organelles found in the cells that power the cell, and they are responsible for generating the energy needed by the cell through a process called cellular respiration. OTC is a key player in this process, as it helps to convert ornithine into the amino acid L-ornithine, which can then be used to produce other amino acids and nucleic acids.

Recent studies have suggested that OTC may be a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. This is because OTC is involved in a wide range of cellular processes that are important for the health and function of cells , and alterations in OTC levels or activity have been observed in a variety of disease conditions.

One potential mechanism by which OTC may be involved in cancer is its role in the regulation of cellular signaling pathways. OTC is a key enzyme in the ornithine transcarbamylase (OTC) gene family, which has been implicated in the development and progression of many types of cancer. For example, studies have shown that OTC levels are often elevated in various types of cancer, and that these changes may be associated with the development of cancer-related traits. Additionally, altered OTC activity has been observed in a variety of cancer- associated proteins, further supporting its role in this process.

Another potential mechanism by which OTC may be involved in neurodegenerative diseases is its role in the production of the amino acid L-ornithine, which is important for the production of neurotransmitters and other molecules that are involved in the function of neural cells. OTC is also involved in the metabolism of the amino acid leucine, which is also important for neurotransmitter synthesis. Alterations in OTC levels or activity have been observed in a variety of neurodegenerative diseases, and these changes may be associated with the progression of these conditions.

In addition to its role in cellular signaling pathways, OTC may also be involved in the regulation of energy metabolism. OTC is a key enzyme in the citric acid cycle, which is the central energy-producing pathway of eukaryotic cells. This pathway is important for the production of ATP, which is the energy currency of the cell. OTC is involved in the final step of this pathway, as it converts L-citrate into the amino acid aspartate, which can then be used to produce ATP. Alterations in OTC levels or activity have been observed in a variety of metabolic disorders, and these changes may be associated with the progression of these conditions.

OTC is also involved in the production of other amino acids and nucleic acids that are important for cellular function. For example, OTC is involved in the production of the amino acids alanine and glutamine, which are important for protein synthesis and cell growth. also involved in the metabolism of nucleic acids, including DNA and RNA, which are important for cellular function and gene expression.

In conclusion, OTC is a protein encoded in the mitochondrial DNA that is involved in a wide range of cellular processes that are important for the health and function of cells. Recent studies have suggested that OTC may be a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. These changes in OTC levels or activity may be associated with the development and progression of these conditions, and may provide valuable insights into the underlying mechanisms of these diseases. Further research is needed to fully understand the The role of OTC in these processes and to develop effective therapies based on this knowledge.

Protein Name: Ornithine Transcarbamylase

Functions: Catalyzes the second step of the urea cycle, the condensation of carbamoyl phosphate with L-ornithine to form L-citrulline (PubMed:6372096, PubMed:8112735, PubMed:2556444). The urea cycle ensures the detoxification of ammonia by converting it to urea for excretion (PubMed:2556444)

The "OTC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OTC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets